Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04892914 · ClinicalTrials.gov registry record · NA
Embr Thermal Device for Hot Flash Management in Prostate Cancer
A NA study of Prostate Cancer and Hot Flashes, sponsored by Embr Labs.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT04892914 is a NA study of Prostate Cancer and Hot Flashes that has completed, run by Embr Labs. The registered enrollment target is 57 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04892914, a NA study of Prostate Cancer and Hot Flashes, has completed, sponsored by Embr Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to evaluate if the Embr thermal device is useful for men who experience bothersome hot flashes as a result of prostate cancer treatment.
Conditions Studied
Interventions
- DEVICE Embr thermal device
Study Locations (1)
Massachusetts
- Embr Labs (Remote study site) - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2021-05-28 |
| Est. Completion | 2021-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04892914
The ClinicalTrials.gov registry entry for NCT04892914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Embr Labs, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Embr thermal device is the first listed.
NCT04892914 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04892914 about?
NCT04892914 is a clinical study titled "Embr Thermal Device for Hot Flash Management in Prostate Cancer". This study is being conducted to evaluate if the Embr thermal device is useful for men who experience bothersome hot flashes as a result of prostate cancer treatment.
What is the current status of trial NCT04892914?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2021-05-28. Estimated completion is 2021-12-05.
What conditions does trial NCT04892914 study?
This clinical trial studies the following conditions: Prostate Cancer, Hot Flashes.
What interventions are being tested in trial NCT04892914?
The interventions under investigation include: Embr thermal device (DEVICE).
Who is sponsoring clinical trial NCT04892914?
This trial is sponsored by Embr Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04892914 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.